Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$566K Buy
3,895
+358
+10% +$49.5K 0.22% 86
2026
Q2
$455K Buy
3,537
+54
+2% +$6.32K 0.18% 95
2026
Q1
$419K Buy
3,483
+328
+10% +$37.9K 0.19% 101
2025
Q4
$332K Sell
3,155
-116
-4% -$10.9K 0.15% 118
2025
Q3
$275K Buy
3,271
+109
+3% +$8.98K 0.12% 136
2025
Q2
$250K Sell
3,162
-62
-2% -$4.93K 0.12% 137
2025
Q1
$289K Sell
3,224
-49
-1% -$4.58K 0.15% 108
2024
Q4
$326K Buy
+3,273
New +$337K 0.15% 110

Other funds holding MRK

FAI Advisors, Inc.'s MRK Position: Q3 2026 in Review

FAI Advisors, Inc. increased its Merck (MRK) stake by 10% in Q3 2026, buying an estimated $49.5K and bringing the position to 3,895 shares worth $566K. The position accounts for 0.22% of the portfolio, ranked #86.

FAI Advisors, Inc. first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 1,488 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • FAI Advisors, Inc. held 3,895 shares of Merck worth $566K as of Q3 2026.
  • FAI Advisors, Inc. bought 358 Merck shares in Q3 2026, an estimated $49.5K.
  • Merck made up 0.22% of FAI Advisors, Inc.'s portfolio in Q3 2026, its #86 holding.
  • FAI Advisors, Inc. first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 1,488 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on FAI Advisors, Inc.'s 13F filing for Q3 2026, filed 27 Oct 2026.